Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B
- PMID: 21198828
- DOI: 10.1111/j.1440-1746.2010.06609.x
Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B
Abstract
Background and aims: Transient elastography (TE) is useful for predicting the fibrosis stage, but it is unsatisfactory as a substitute for liver biopsy, especially in patients with chronic hepatitis B (CHB). This study was performed to establish a reliable model for predicting significant fibrosis (SF) in patients with CHB.
Methods: All CHB patients who were admitted to undergo liver biopsy were enrolled. They were randomly classified into either a training set (n = 139) or a validation set (n = 69). A model for predicting SF was established in the training set and validated in the validation set. Low and high cutoff values (COVs) were chosen for sensitivity ≥ 99% and specificity ≥ 99%, respectively.
Results: A total of 208 patients were enrolled. Age was 39 ± 12 years and 149 (71.6%) were men. In the training set, liver stiffness values and serum haptoglobin, apolipoprotein A1, and α2-macroglobulin levels were independent predictors of SF on multivariate analysis. These variables were used to construct a novel model, called the HALF index. The area under the receiver operating characteristics curve of the HALF index for predicting SF was significantly higher than that of TE alone (0.915 vs 0.877, P = 0.010). Using low and high COVs of the HALF index, it appears that approximately half (47.1%) of patients could avoid liver biopsy, with an associated accuracy of 99.0%.
Conclusion: A combination of liver stiffness and serum markers identified SF with a high degree of accuracy. Approximately half of all patients with CHB could avoid liver biopsy through the utilization of the HALF index.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Comment in
-
Non-invasive assessment of liver fibrosis: the gap between ideal and real.J Gastroenterol Hepatol. 2011 Jun;26(6):937-9. doi: 10.1111/j.1440-1746.2011.06741.x. J Gastroenterol Hepatol. 2011. PMID: 21564284 No abstract available.
Similar articles
-
Non-invasive assessment of liver fibrosis: the gap between ideal and real.J Gastroenterol Hepatol. 2011 Jun;26(6):937-9. doi: 10.1111/j.1440-1746.2011.06741.x. J Gastroenterol Hepatol. 2011. PMID: 21564284 No abstract available.
-
Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.J Gastroenterol Hepatol. 2010 Jan;25(1):94-100. doi: 10.1111/j.1440-1746.2009.05953.x. Epub 2009 Sep 27. J Gastroenterol Hepatol. 2010. PMID: 19793171
-
Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients.J Gastroenterol Hepatol. 2011 Mar;26(3):492-500. doi: 10.1111/j.1440-1746.2010.06419.x. J Gastroenterol Hepatol. 2011. PMID: 21332545
-
Noninvasive methods to assess liver disease in patients with hepatitis B or C.Gastroenterology. 2012 May;142(6):1293-1302.e4. doi: 10.1053/j.gastro.2012.02.017. Gastroenterology. 2012. PMID: 22537436 Review.
-
FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Am J Gastroenterol. 2014 Jun;109(6):796-809. doi: 10.1038/ajg.2014.21. Epub 2014 Feb 18. Am J Gastroenterol. 2014. PMID: 24535095 Review.
Cited by
-
Development and Validation of a Non-invasive Model to Predict Liver Histological Lesions in Chronic Hepatitis B Patients With Persistently Normal Alanine Aminotransferase and Detectable Viremia.Front Med (Lausanne). 2022 Jul 13;9:944547. doi: 10.3389/fmed.2022.944547. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35911415 Free PMC article.
-
The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.Lipids Health Dis. 2016 Mar 25;15:64. doi: 10.1186/s12944-016-0232-5. Lipids Health Dis. 2016. PMID: 27015844 Free PMC article.
-
Clinical applications, limitations and future role of transient elastography in the management of liver disease.World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):91-106. doi: 10.4292/wjgpt.v7.i1.91. World J Gastrointest Pharmacol Ther. 2016. PMID: 26855815 Free PMC article. Review.
-
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.World J Gastroenterol. 2014 Sep 14;20(34):12031-8. doi: 10.3748/wjg.v20.i34.12031. World J Gastroenterol. 2014. PMID: 25232240 Free PMC article. Review.
-
The use of transient elastography in the management of chronic hepatitis B.Hepatol Int. 2011 Jun 22;5(4):868-875. doi: 10.1007/s12072-011-9288-5. eCollection 2011 Dec. Hepatol Int. 2011. PMID: 21695588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous